Resources

Virtual care has become increasingly important during the COVID-19 epidemic. Virtual care, sometimes referred to as telemedicine, includes the use of video and telephone platforms...

The Canadian Rheumatology Association (CRA) is committed to supporting its members in their efforts to continue to deliver optimal care for their patients with rheumatic diseases. At the same time, the CRA acknowledges the gravity of the situation with the […]

Pain is a prevalent and often severe symptom that impacts global health status for almost every patient with a rheumatic disease. In response to the Guideline for opioid therapy and chronic non-cancer pain published in the Canadian Medical Association Journal...

The medical management of juvenile idiopathic arthritis (JIA) and its complications has undergone significant changes in the last decade, a result largely of the introduction of biologics and increased availability of expertise in the diagnosis and management of rheumatic diseases […]

Algorithm for the Management of High Dose (150 mg daily) Diclofenac Usage in Chronic Pain Patients.

This metanalysis deals with the risks of cardiovascular and gastrointestinal events and deaths with the use of high-dose COX-2 inhibitors, diclofenac, and naproxen compared to placebo.. Reviewed by Therapeutics Committee in November 2021 and no changes made.